TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties

References

• Bonnefoy F, Couturier M, Clauzon A, et al. (2011). TGF-β-exposed plasmacytoid dendritic cells participate in Th17 commitment. J Immunol, 186, 6157–64
   Google Scholar
• Chen L, Qiu M, He W, et al. (2012). Functional study of immature dendritic cells co-transfected with IL-10 and TGF-beta 1 genes in vitro. Mol Biol Rep, 39, 6633–9
   Google Scholar
• Cools N, Van Tendeloo VF, Smits EL, et al. (2008). Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double positive CD4+ regulatory T cells. J Cell Mol Med, 12, 690–700
   PubMed Web of Science ®Google Scholar
• den Hartog G, van Altena C, Savelkoul HF, van Neerven RJ. (2013). The mucocal factors retinoic acid and TGF-β1 induce phenotypically and functional distinct dendritic cell types. Int Arch Allergy Immunol, 162, 225–36
   PubMed Web of Science ®Google Scholar
• Fogel-Petrovic M, Long JA, Misso NL, et al. (2007). Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function. Int Immunopharmacol, 7, 1924–33
   Google Scholar
• Griffiths KL, O’Neill HC. (2008). Dendritic cells as immune regulators: the mouse model. J Cell Mol Med, 12, 1909–14
   Google Scholar
• Harden JL, Egilmez NK. (2012). Indoleamine 2,3-Dioxygenase and Dendritic cell Tolerogenicity. Immunol Invest, 41, 738–64
   PubMed Web of Science ®Google Scholar
• Irie-Sasaki J, Sasaki T, Matsumoto W, et al. (2001). CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature, 409, 349–54
   PubMed Web of Science ®Google Scholar
• Johnson TS, Munn DH. (2012). Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance. Immunol Invest, 41, 765–97
   PubMed Web of Science ®Google Scholar
• Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. (2010). TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol, 185, 3248–55
   PubMed Web of Science ®Google Scholar
• Liu N, Duan TD, Zheng N. (2006). Effects of TGF-beta 1, gene modified donor dendritic cells on immune repulsion. Sichuan Da Xue Xue Bao Yi Xue Ban, 37, 721–5
   Google Scholar
• Liu QY, Yao YM, Zhang SW, Sheng ZY. (2011). Astragalus polysaccharides regulate T cell-mediated immunity via CD11clowCD45RBhigh dendritic cells in vitro. J Ethnopharmacol, 136, 457–64
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang P, Li J, et al. (2008). A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol, 9, 632–40
   PubMed Web of Science ®Google Scholar
• Lob S, Konigsrainer A, Rammensee HG, et al. (2009). Inhibitors of indoleamine 2,3-dioxygenase for cancer therapy: can we see the wood for trees. Nat Rev Cancer, 9, 445–52
   PubMed Web of Science ®Google Scholar
• Mantel PY, Schmidt-Weber CB. (2011). Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol, 677, 303–38
   PubMedGoogle Scholar
• Matteoli G, Mazzini E, Iliev ID, et al. (2010). Gut CD103+ dendritic cells express indoleamine 2, 3-dioxygenase which influence T regulatory/T effectorcell balance and oral tolerance induction. Gut, 59, 595–604
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. (2004). IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol, 4, 762–74
   PubMed Web of Science ®Google Scholar
• Messmer D, Hatsukari I, Hitosugi N, et al. (2006). Morphine reciprocally regulates IL-0 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol Med, 12, 284–90
   Google Scholar
• Nasef A, Chapel A, Mazurier C, et al. (2007). Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human msenchymal stem cells. Gene Expr, 13, 217–26
   PubMed Web of Science ®Google Scholar
• Park J, Babensee JE. (2012). Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater, 8, 3606–17
   PubMed Web of Science ®Google Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex II compartment: downregulation by cytokines and bacterial products. J Exp Med, 182, 389–400
   PubMed Web of Science ®Google Scholar
• Son CH, Bae JH, Shin DY, et al. (2013). Enhanced maturation and function of dendritic cells using hydrogel coated plate and antigen electroporation. Immunol Invest, 42, 341–55
   PubMed Web of Science ®Google Scholar
• Spender LC, O,Brien DI, Simpson D, et al. (2009). TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ, 16, 593–602
   PubMed Web of Science ®Google Scholar
• Takamatsu M, Hirata A, Ohtaki H, et al. (2013). IDO plays an immunosuppressive role in 2, 4, 6-Trinitrobenzene sulfate-induced colitis in mice. J Immunol, 191, 3057–64
   PubMed Web of Science ®Google Scholar
• Ureta G, Osorio F, Morales J, et al. (2007). Generation of dendritic cells with regulatory properties. Transpl Proc, 9, 633–7
   Google Scholar
• Von Bubnoff D, Scheler M, Wilms H, et al. (2011). Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol, 186, 6701–9
   PubMed Web of Science ®Google Scholar
• Yan YH, Shang PZ, Lu QJ, Wu X. (2012). Triptolide regulates cell-mediated immunity via induction of CD11clow dendritic cell differentiation. Food Chem Toxicol, 50, 2560–4
   Google Scholar
• Yang L, Pang Y, Moses HL. (2010). TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol, 31, 220–7
   PubMed Web of Science ®Google Scholar
• Ye Z, Huang H, Hao S, et al. (2007). L-10 has a distinct immunoregulatory effect on naive and active T cell subsets. J Interferon Cytokine Res, 27, 1031–8
   Google Scholar
• Zaher SS, Germain C, Fu H, et al. (2011). 3-hydroxykynurenine suppresses CD14+ T-cell proliferation, induces T-regulatory-cell development and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci, 52, 2640–8
   PubMed Web of Science ®Google Scholar